ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 441,159 | $39,788,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,100 | $9,286,000 | 2.24% |
Rock Springs Capital Management LP | 801,109 | $72,252,000 | 1.52% |
Avidity Partners Management LP | 455,000 | $41,036,000 | 0.91% |
Motley Fool Asset Management LLC | 134,357 | $12,118,000 | 0.79% |
FEDERATED HERMES, INC. | 3,987,032 | $359,590,000 | 0.68% |
EMERALD ADVISERS, LLC | 196,124 | $17,688,000 | 0.64% |
Ergoteles LLC | 128,100 | $11,553,000 | 0.42% |
Tekla Capital Management LLC | 140,726 | $12,692,000 | 0.41% |
Beck Bode, LLC | 14,990 | $1,352,000 | 0.38% |